David Hetzel

Innovative healthcare leader researcher and seasoned oncologist over 25 years of experience in clinical, surgical, and research settings. Entrepreneur (successful HMRX PACS System and Hope WCC medical) with expertise in developing SmartTech medical devices, integrating technology with healthcare to improve patient outcomes. Proven track record of leading large multidisciplinary teams, designing and executing complex clinical and operational strategies, and spearheading cutting-edge research in oncology.

Author / Strategist of ContextuaLife AI.

CEO, Designer, and Founder at Secure Surgical Inc. (2013-01 – Present)

• Developed and launched innovative medical devices, including a patented breast localization system enhancing peri-operative surgical accuracy.
• Established an AI-driven device communication system with international and US patents pending.
• Scaled the company from concept to a recognized name in medical device innovation, securing multiple USP awards.
• Led the development and successful exit of a PACS network, improving imaging efficiency across four centers.
• ContextuaLife™ AI a right hemisphere (brain) dominant AI strategy, focusing on context driven neurocognitive inspired solutions for dealing with uncertainty, complexity, ambiguity, and moral decision making.

Gynecologic Oncologist, Pelvic and Breast Cancer Surgeon at Hope Women's Cancer Centers & Mission Health UNC Cancer (1997-01 – 2020-12)

• Developer (Program / Team) and primary Strategist of two Hope comprehensive women's cancer centers.
• Co-founder and CEO leading a team of 100+ across two US States serving a 45-county referral area.
• Developed and managed two chemotherapy infusion centers and imaging centers, enhancing regional cancer care. Developed a vertically oriented delivery system: clinical, surgical, imaging, infusion, research
• Spearheaded women's cancer research initiatives, with significant advancements in treatment protocols.
• Director of Breast Fellowship at Hope WCC for the Society of Gynecologic Oncology, mentoring future leaders and practitioners in women's surgical oncology.
• Collaborated with clinical and research teams to innovate and implement new cancer therapies, influencing national standards.

Associate Clinical Professor of Obstetrics and Gynecology at University of North Carolina - Chapel Hill (2010-01 – 2020-12)

• Educated and mentored medical students, residents, and fellows in the latest advancements in obstetrics and gynecology.
• Conducted groundbreaking research on the immuno-histochemical analysis of cancer, published in leading medical journals.
• Engaged in clinical trials as Principal Investigator, significantly contributing to the development of novel cancer treatments.
• Delivered expert lectures on complex oncological cases, advancing the field of women's cancer care.
• Actively involved in the formulation of clinical practice guidelines, influencing national standards in gynecologic and breast oncology.

MBA in Business Administration – University of North Carolina, Kenan-Flagler Business School (2012-01 – 2014-12)

Fellowship in Gynecologic Oncology – Pennsylvania State College of Medicine (1992-01 – 1994-12)

Residency in Obstetrics and Gynecology – Mayo Graduate School of Medicine (1988-01 – 1992-12)

MD in Medicine – Medical College of Wisconsin (1984-01 – 1988-12)

Bachelor of Science in Biology and Chemistry – University of Wisconsin-La Crosse (1979-01 – 1983-12)